| Obstacles and opportunities in a forward vision for cancer nanomedicine I de Lázaro, DJ Mooney Nature Materials 20 (11), 1469-1479, 2021 | 300 | 2021 |
| Viscoelastic surface electrode arrays to interface with viscoelastic tissues CM Tringides, N Vachicouras, I de Lázaro, H Wang, A Trouillet, BR Seo, ... Nature Nanotechnology 16 (9), 1019-1029, 2021 | 215 | 2021 |
| Matrix viscoelasticity controls spatio-temporal tissue organization A Elosegui-Artola, A Gupta, AJ Najibi, BR Seo, R Garry, CM Tringides, ... Nature Materials 22, 117-127, 2022 | 150 | 2022 |
| A nanoparticle’s pathway into tumours I de Lázaro, DJ Mooney Nature Materials 19 (5), 486-487, 2020 | 147 | 2020 |
| Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics? I de Lázaro, A Yilmazer, K Kostarelos Journal of Controlled Release 185, 37-44, 2014 | 87 | 2014 |
| Graphene materials as 2D non-viral gene transfer vector platforms M Vincent, I De Lázaro, K Kostarelos Gene therapy 24 (3), 123-132, 2017 | 81 | 2017 |
| Skeletal muscle regeneration with robotic actuation–mediated clearance of neutrophils BR Seo, CJ Payne, SL McNamara, BR Freedman, BJ Kwee, S Nam, ... Science Translational Medicine 13 (614), eabe8868, 2021 | 71 | 2021 |
| Splenic Capture and In Vivo Intracellular Biodegradation of Biological-Grade Graphene Oxide Sheets L Newman, DA Jasim, E Prestat, N Lozano, I de Lazaro, Y Nam, ... ACS nano 14 (8), 10168-10186, 2020 | 70 | 2020 |
| In vivo cell reprogramming towards pluripotency by virus-free overexpression of defined factors A Yilmazer, I de Lázaro, C Bussy, K Kostarelos PloS one 8 (1), e54754, 2013 | 51 | 2013 |
| Peptide nanofiber complexes with siRNA for deep brain gene silencing by stereotactic neurosurgery M Mazza, M Hadjidemetriou, I de Lazaro, C Bussy, K Kostarelos ACS nano 9 (2), 1137-1149, 2015 | 46 | 2015 |
| Thermal monitoring during photothermia: hybrid probes for simultaneous plasmonic heating and near-infrared optical nanothermometry M Quintanilla, I García, I de Lázaro, R García-Alvarez, M Henriksen-Lacey, ... Theranostics 9 (24), 7298, 2019 | 44 | 2019 |
| Graphene oxide as a 2d platform for complexation and intracellular delivery of sirna I de Lázaro, S Vranic, D Marson, AF Rodrigues, M Buggio, ... Nanoscale 11 (29), 13863-13877, 2019 | 44 | 2019 |
| Non-viral, tumor-free induction of transient cell reprogramming in mouse skeletal muscle to enhance tissue regeneration I de Lázaro, A Yilmazer, Y Nam, S Qubisi, FMA Razak, H Degens, ... Molecular Therapy, 2018 | 35* | 2018 |
| Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming I de Lázaro, G Cossu, K Kostarelos EMBO molecular medicine 9 (6), 733-736, 2017 | 34 | 2017 |
| Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model I de Lázaro, P Sharp, C Gurcan, A Ceylan, M Stylianou, T Kisby, Y Chen, ... Advanced Therapeutics 4 (1), 2000109, 2021 | 26 | 2021 |
| Reprogramming cancer cells: A novel approach for cancer therapy or a tool for disease-modeling? A Yilmazer, I de Lázaro, H Taheri Cancer letters 369 (1), 1-8, 2015 | 22 | 2015 |
| Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells I de Lázaro, C Bussy, A Yilmazer, MS Jackson, NE Humphreys, ... Biomaterials 35 (29), 8312-8320, 2014 | 22 | 2014 |
| In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors A Yilmazer, I de Lázaro, C Bussy, K Kostarelos JoVE (Journal of Visualized Experiments), e50837, 2013 | 19 | 2013 |
| Adenoviral Mediated Delivery of OSKM Factors Induces Partial Reprogramming of Mouse Cardiac Cells In Vivo T Kisby, I de Lázaro, S Fisch, EJ Cartwright, G Cossu, K Kostarelos Advanced Therapeutics 4 (2), 2000141, 2021 | 17 | 2021 |
| Microporogen‐Structured Collagen Matrices for Embedded Bioprinting of Tumor Models for Immuno‐Oncology DS Reynolds, I de Lázaro, ML Blache, Y Liu, NC Jeffreys, RM Doolittle, ... Advanced Materials 35 (33), 2210748, 2023 | 15 | 2023 |
Kostas KostarelosNanomedicine Lab, ICREA & ICN2, Barcelona, Spain and University of Manchester, UKAdresse e-mail validée de icn2.cat
